Stay updated on Troriluzole Long-term Safety in OCD Clinical Trial
Sign up to get notified when there's something new on the Troriluzole Long-term Safety in OCD Clinical Trial page.

Latest updates to the Troriluzole Long-term Safety in OCD Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe ClinicalTrials.gov site footer revision changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check18 days agoChange DetectedA banner announces an NIH-wide terminology transition, stating that “Super Intelligence” may replace “Artificial Intelligence” across NIH content.SummaryDifference0.5%

- Check25 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check32 days agoChange DetectedThe site footer now identifies the ClinicalTrials.gov release as v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check53 days agoChange DetectedA new revision entry (v3.7.0) was added to the study record history and the older revision (v3.6.6) was removed, updating the record's version history.SummaryDifference0.1%

- Check74 days agoChange DetectedThe history log now includes a new Revision: v3.6.6 entry, and the previous Revision: v3.6.5 is removed. This reflects a minor backend update to the versioning metadata without impacting study data or user-facing content.SummaryDifference0.1%

Stay in the know with updates to Troriluzole Long-term Safety in OCD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Troriluzole Long-term Safety in OCD Clinical Trial page.